Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 5
2005 1
2006 6
2007 3
2008 4
2009 2
2010 4
2011 2
2012 2
2013 1
2014 1
2015 3
2016 5
2017 6
2018 3
2019 4
2020 7
2021 13
2022 5
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Guideline for the management of myasthenic syndromes.
Wiendl H, Abicht A, Chan A, Della Marina A, Hagenacker T, Hekmat K, Hoffmann S, Hoffmann HS, Jander S, Keller C, Marx A, Melms A, Melzer N, Müller-Felber W, Pawlitzki M, Rückert JC, Schneider-Gold C, Schoser B, Schreiner B, Schroeter M, Schubert B, Sieb JP, Zimprich F, Meisel A. Wiendl H, et al. Among authors: schneider gold c. Ther Adv Neurol Disord. 2023 Dec 26;16:17562864231213240. doi: 10.1177/17562864231213240. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 38152089 Free PMC article. Review.
Advances and challenges in the treatment of myasthenia gravis.
Schneider-Gold C, Gilhus NE. Schneider-Gold C, et al. Ther Adv Neurol Disord. 2021 Dec 21;14:17562864211065406. doi: 10.1177/17562864211065406. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 34987614 Free PMC article. Review.
Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society.
Melzer N, Ruck T, Fuhr P, Gold R, Hohlfeld R, Marx A, Melms A, Tackenberg B, Schalke B, Schneider-Gold C, Zimprich F, Meuth SG, Wiendl H. Melzer N, et al. Among authors: schneider gold c. J Neurol. 2016 Aug;263(8):1473-94. doi: 10.1007/s00415-016-8045-z. Epub 2016 Feb 17. J Neurol. 2016. PMID: 26886206 Free PMC article. Review.
The emerging spectrum of fetal acetylcholine receptor antibody-related disorders (FARAD).
Allen NM, O'Rahelly M, Eymard B, Chouchane M, Hahn A, Kearns G, Kim DS, Byun SY, Nguyen CE, Schara-Schmidt U, Kölbel H, Marina AD, Schneider-Gold C, Roefke K, Thieme A, Van den Bergh P, Avalos G, Álvarez-Velasco R, Natera-de Benito D, Cheng MHM, Chan WK, Wan HS, Thomas MA, Borch L, Lauzon J, Kornblum C, Reimann J, Mueller A, Kuntzer T, Norwood F, Ramdas S, Jacobson LW, Jie X, Fernandez-Garcia MA, Wraige E, Lim M, Lin JP, Claeys KG, Aktas S, Oskoui M, Hacohen Y, Masud A, Leite MI, Palace J, De Vivo D, Vincent A, Jungbluth H. Allen NM, et al. Among authors: schneider gold c. Brain. 2023 Oct 3;146(10):4233-4246. doi: 10.1093/brain/awad153. Brain. 2023. PMID: 37186601 Free PMC article.
Understanding the burden of refractory myasthenia gravis.
Schneider-Gold C, Hagenacker T, Melzer N, Ruck T. Schneider-Gold C, et al. Ther Adv Neurol Disord. 2019 Mar 1;12:1756286419832242. doi: 10.1177/1756286419832242. eCollection 2019. Ther Adv Neurol Disord. 2019. PMID: 30854027 Free PMC article. Review.
Seronegative myasthenic crisis: a multicenter analysis.
Mergenthaler P, Stetefeld HR, Dohmen C, Kohler S, Schönenberger S, Bösel J, Gerner ST, Huttner HB, Schneider H, Reichmann H, Fuhrer H, Berger B, Zinke J, Alberty A, Kleiter I, Schneider-Gold C, Roth C, Dunkel J, Steinbrecher A, Thieme A, Lee DH, Linker RA, Angstwurm K, Meisel A, Neumann B; German Myasthenic Crisis Study Group. Mergenthaler P, et al. Among authors: schneider gold c. J Neurol. 2022 Jul;269(7):3904-3911. doi: 10.1007/s00415-022-11023-z. Epub 2022 Apr 7. J Neurol. 2022. PMID: 35389099 Free PMC article.
Gender issues of antibody-mediated diseases in neurology: (NMOSD/autoimmune encephalitis/MG).
Altintas A, Dargvainiene J, Schneider-Gold C, Asgari N, Ayzenberg I, Ciplea AI, Junker R, Leypoldt F, Wandinger KP, Hellwig K. Altintas A, et al. Among authors: schneider gold c. Ther Adv Neurol Disord. 2020 Aug 25;13:1756286420949808. doi: 10.1177/1756286420949808. eCollection 2020. Ther Adv Neurol Disord. 2020. PMID: 32922516 Free PMC article. Review.
COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis.
Faissner S, Richter D, Ceylan U, Schneider-Gold C, Gold R. Faissner S, et al. Among authors: schneider gold c. J Neurol. 2022 Apr;269(4):1774-1775. doi: 10.1007/s00415-021-10768-3. Epub 2021 Aug 25. J Neurol. 2022. PMID: 34435250 Free PMC article. No abstract available.
Correlates of polyneuropathy in Parkinson's disease.
Kühn E, Averdunk P, Huckemann S, Müller K, Biesalski AS, Hof Zum Berge F, Motte J, Fisse AL, Schneider-Gold C, Gold R, Pitarokoili K, Tönges L. Kühn E, et al. Among authors: schneider gold c. Ann Clin Transl Neurol. 2020 Oct;7(10):1898-1907. doi: 10.1002/acn3.51182. Epub 2020 Sep 17. Ann Clin Transl Neurol. 2020. PMID: 32940017 Free PMC article.
78 results